Joint Health

Broodmare Body Condition & Developmental Orthopaedic Disease (DOD) Risk in Foals, Weanlings and Yearlings

Broodmare Body Condition & Developmental Orthopaedic Disease (DOD) Risk in Foals, Weanlings and Yearlings

Most breeders focus on broodmare nutrition in late pregnancy or once the foal is at foot. However, how you feed and manage your broodmare year-round has a direct and lasting

Broodmare Body Condition & Developmental Orthopaedic Disease (DOD) Risk in Foals, Weanlings and Yearlings Read More »

Broodmare nutrient requirements, foetal growth rate and the influence of nutrition on the skeletal health of a mare’s offspring

Broodmare nutrient requirements, foetal growth rate and the influence of nutrition on the skeletal health of a mare’s offspring

A mare’s nutritional requirements vary throughout different stages of her pregnancy, with the last three to four months placing the most significant nutritional demands on the mare. This is a

Broodmare nutrient requirements, foetal growth rate and the influence of nutrition on the skeletal health of a mare’s offspring Read More »

Optim-Equine-Off-The-Track-Thoroughbreds

An Introduction to Off The Track Thoroughbreds (OTTB)

Among the many breeds and types of horses available to riders, off the track thoroughbreds (OTTB) are a highly popular choice of mount. And for a very good reason! Their

An Introduction to Off The Track Thoroughbreds (OTTB) Read More »

Optim-Equine-Feed-formulation-and-broodmares

Coco Pops, Feeding Broodmares and Skeletal Development…What’s the Link?

When it comes to feeding our broodmares, we are inundated with choices in terms of commercial feed mixes and concentrates. It’s common for our feed selections to be largely influenced

Coco Pops, Feeding Broodmares and Skeletal Development…What’s the Link? Read More »

Bisphosphonates-(Tildren-&-Osphos)-Time-to-talk-about-the-Skeleton-in-the-Closet-Optim-Equine

Bisphosphonates (Tildren & Osphos): Understanding how they work and their role in bone health

Bisphosphonates are a class of drugs which includes both tildronate and clodronate. They were approved by the U.S. Food and Drug Administration in 2014 for controlling clinical signs associated with navicular syndrome in

Bisphosphonates (Tildren & Osphos): Understanding how they work and their role in bone health Read More »